CRL Stock — Charles River Laboratories International Inc.

Charles River Laboratories International Inc. (CRL)

Updated October 16, 2026.

CRL is a Stock. Total return is 1264.3% over the past 26.3 years, 522.6 points ahead of SPY at 741.7%.

Charles River Laboratories International provides drug discovery, non-clinical development, and safety testing services for the pharmaceutical and biotechnology industries, operating three main segments: Research Models and Services (producing research animals and related services), Discovery and Safety Assessment (offering preclinical testing and toxicology services), and Manufacturing Solutions (providing quality control testing and contract manufacturing for pharmaceuticals and biologics). The company does not currently have an established distribution frequency.

CRL performance versus SPY

Price and return data through 2026-10-16.

Total return is 1264.3% over the past 26.3 years, 522.6 points ahead of SPY at 741.7%. Over the past year its total return — price change plus distributions reinvested — is 71.6%. Its deepest 1-year drawdown was 33.9%.

CRL key facts

Asset type

Stock

Asset class

Equity

Inception date

06/23/2000

Distribution frequency

None

Last close

$300.15 (as of 2026-10-16)

Market cap

$14,328,822,431

Average volume

674573.0

Beta

1.404

Payout ratio

0.0%

Forward P/E

22.4215

EPS

$-4.76

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

CRL risks and drawbacks

The deepest 1-year drawdown on record here is 33.9%.

Who may consider CRL — and who may not

It is a weaker fit for investors who need monthly cash flow (CRL does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on CRL

• All tickers starting with C

Tagged: Healthcare.

Frequently asked questions